S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
Tech Stocks to Sink Your Teeth into in 2022
3 Trustworthy High-Yield Dividend Stocks to Buy Now
3 Heavily Shorted Stocks With Squeeze Potential
3 Financially Fit Airline Stocks Worth Boarding
Should You Buy The Dip In JPMorgan (NYSE: JPM) Stock?
United Health’s Guidance Gives Investors A Chill 
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
Tech Stocks to Sink Your Teeth into in 2022
3 Trustworthy High-Yield Dividend Stocks to Buy Now
3 Heavily Shorted Stocks With Squeeze Potential
3 Financially Fit Airline Stocks Worth Boarding
Should You Buy The Dip In JPMorgan (NYSE: JPM) Stock?
United Health’s Guidance Gives Investors A Chill 
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
Tech Stocks to Sink Your Teeth into in 2022
3 Trustworthy High-Yield Dividend Stocks to Buy Now
3 Heavily Shorted Stocks With Squeeze Potential
3 Financially Fit Airline Stocks Worth Boarding
Should You Buy The Dip In JPMorgan (NYSE: JPM) Stock?
United Health’s Guidance Gives Investors A Chill 
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
Tech Stocks to Sink Your Teeth into in 2022
3 Trustworthy High-Yield Dividend Stocks to Buy Now
3 Heavily Shorted Stocks With Squeeze Potential
3 Financially Fit Airline Stocks Worth Boarding
Should You Buy The Dip In JPMorgan (NYSE: JPM) Stock?
United Health’s Guidance Gives Investors A Chill 
NASDAQ:NUVA

NuVasive Earnings Date, Estimates, & History

$55.44
-0.36 (-0.65%)
(As of 01/19/2022 12:00 AM ET)
Add
Compare
Today's Range
$55.27
▼
$57.12
50-Day Range
$47.19
▼
$58.90
52-Week Range
$45.45
▼
$72.61
Volume
542,678 shs
Average Volume
569,140 shs
Market Capitalization
$2.87 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.21

Earnings Summary

Upcoming
Earnings Date
Feb. 24
Estimated

Actual EPS
(Nov. 9)
$0.32
Missed By -$0.22

Consensus EPS
(Nov. 9)
$0.54

Last Year's Q4 EPS
(10/29/2020)
$0.55

Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

NuVasive Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NuVasive Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NuVasive (NASDAQ:NUVA) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20223$0.43$0.51$0.46 
Q2 20223$0.52$0.64$0.58 
Q3 20222$0.44$0.57$0.51 
Q4 20223$0.60$0.79$0.69 
FY 202211$1.99$2.51$2.23
Q1 20231$0.61$0.61$0.61 
Q2 20231$0.65$0.65$0.65 
Q3 20231$0.63$0.63$0.63 

NUVA Earnings Information

NuVasive last announced its quarterly earnings data on November 9th, 2021. The medical device company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.54 by $0.22. The company earned $270.84 million during the quarter, compared to the consensus estimate of $291.32 million. NuVasive has generated ($0.51) earnings per share over the last year (($0.51) diluted earnings per share). Earnings for NuVasive are expected to grow by 30.51% in the coming year, from $1.77 to $2.31 per share. NuVasive has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 24th, 2022 based off prior year's report dates.

NuVasive (NASDAQ:NUVA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
2/24/2022
(Estimated)		        
11/9/20219/30/2021$0.54$0.32($0.22)$1.06$291.32 million$270.84 million    
7/28/20216/30/2021$0.43$0.60+$0.17$1.17$286.17 million$294.83 million    
5/5/20213/31/2021$0.35$0.37+$0.02$0.89$261.12 million$271.25 million  
2/25/202112/31/2020$0.55$0.59+$0.04$1.15$298.51 million$291.81 million  
10/29/20209/30/2020$0.24$0.55+$0.31$0.97$257.70 million$295.30 million  
8/4/20206/30/2020($0.47)($0.40)+$0.07$0.18$203.67 million$203.61 million  
5/6/20203/31/2020$0.41$0.48+$0.07$0.86$262.32 million$259.88 million  
2/20/2020Q4 2019$0.64$0.73+$0.09$0.91$304.93 million$310.40 million  
10/30/2019Q3 2019$0.53$0.59+$0.06$0.97$283.75 million$290.80 million  
7/30/2019Q2$0.56$0.63+$0.07$0.97$290.59 million$292.11 million  
5/1/20193/31/2019$0.41$0.53+$0.12$0.88$269.22 million$274.78 million  
2/20/201912/31/2018$0.63$0.69+$0.06$1.15$290.85 million$288.30 million  
10/30/20189/30/2018$0.62$0.56($0.06)$0.82$265.70 million$271.30 million  
7/31/2018Q2 2018$0.58$0.58$0.94$276.05 million$281.56 million
5/1/2018Q1 2018$0.45$0.39($0.06)$1.31$259.43 million$260.50 million  
2/26/2018Q4 2017$0.56$0.56$0.66$272.11 million$271.70 million  
10/24/2017Q3 2017$0.48$0.52+$0.04$0.40$255.70 million$247.40 million
7/27/2017Q2 2017$0.4440$0.46+$0.0160$0.70$261.95 million$260.60 million
4/25/2017Q1 2017$0.37$0.38+$0.01$0.54$250.52 million$249.86 million
2/9/2017Q416$0.51$0.53+$0.02$0.95$261.25 million$271.10 million  
10/25/2016Q316$0.40$0.40$0.73$243.49 million$239.60 million  
7/26/2016Q216$0.36$0.40+$0.04$0.23$232.86 million$236.50 million  
4/26/2016Q116$0.27$0.31+$0.04$0.81$205.54 million$215.10 million  
2/11/2016Q415$0.31$0.35+$0.04$0.48$215.08 million$215.30 million  
10/27/2015Q315$0.27$0.35+$0.08$0.46$200.21 million$200.50 million  
7/28/2015Q215$0.25$0.31+$0.06$0.42$200.71 million$202.91 million  
5/4/2015Q115$0.21$0.30+$0.09($0.01)$189.30 million$192.40 million  
2/24/2015Q4$0.37$0.39+$0.02$0.43$201.40 million$204.30 million  
10/30/2014Q314$0.14$0.09($0.05)$0.22$179.30 million$189.90 million  
7/29/2014Q214$0.25$0.28+$0.03$0.33$177.50 million$190.70 million  
4/29/2014Q114$0.13$0.29+$0.16$0.78$171.30 million$177.50 million  
3/3/2014Q4 2013$0.17$0.25+$0.08$0.37$181.24 million$190.80 million  
10/29/2013Q3 2013$0.13$0.28+$0.15$0.40$158.30 million$169.20 million  
7/30/2013Q2 2013$0.13$0.09($0.04)$0.33$161.67 million$165.70 million  
4/30/2013Q1 2013$0.11$0.17+$0.06$0.32$157.34 million$159.50 million  
2/26/2013Q4 2012$0.21$0.34+$0.13$156.35 million$165.80 million  
10/24/2012$0.21$0.23+$0.02  
7/25/2012$0.23$0.27+$0.04  
4/30/2012$0.18$0.20+$0.02  
2/22/2012$0.22$0.27+$0.05  
10/27/2011$0.24$0.26+$0.02
7/25/2011$0.28$0.30+$0.02
5/5/2011$0.19$0.24+$0.05
2/23/2011$0.42$0.46+$0.04
10/28/2010Q3 2010$0.26$0.29+$0.03$0.37
7/27/2010Q2 2010$0.18$0.24+$0.06$0.31
4/20/2010Q1 2010$0.07$0.09+$0.02$0.15
2/25/2010Q4 2009$0.11$0.11$0.16
10/20/2009Q3 2009$0.05$0.15+$0.10$0.17
7/23/2009Q2 2009($0.02)$0.07+$0.09$0.07
4/22/2009Q1 2009($0.20)($0.02)+$0.18$0.08
2/25/2009Q4 2008$0.12$0.16+$0.04$0.22
10/22/2008Q3 2008$0.01$0.04+$0.03$0.72
7/24/2008Q2 2008($0.03)($0.01)+$0.02($0.01)
4/22/2008Q1 2008($0.10)($0.10)$0.02
2/19/2008Q4 2007($0.04)($0.03)+$0.01($0.03)
(Earnings results data provided by Zacks Investment Research)












NuVasive (NASDAQ:NUVA) Earnings Frequently Asked Questions

When is NuVasive's earnings date?

NuVasive has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 24th, 2022 based off last year's report dates. Learn more on NUVA's earnings history

Did NuVasive beat their earnings estimates last quarter?

In the previous quarter, NuVasive (NASDAQ:NUVA) missed the analysts' consensus estimate of $0.54 by $0.22 with a reported earnings per share (EPS) of $0.32. Learn more on NUVA's earnings details

How can I listen to NuVasive's earnings conference call?

The conference call for NuVasive's latest earnings report can be listened to online. Listen to Conference Call

How can I read NuVasive's conference call transcript?

The conference call transcript for NuVasive's latest earnings report can be read online. Read Transcript

How much revenue does NuVasive generate each year?

NuVasive (NASDAQ:NUVA) has a recorded annual revenue of $1.05 billion.

How much profit does NuVasive generate each year?

NuVasive (NASDAQ:NUVA) has a recorded net income of -$37.15 million. NUVA has generated -$0.51 earnings per share over the last four quarters.

What is NuVasive's price-to-earnings ratio?

NuVasive (NASDAQ:NUVA) has a forward price-to-earnings ratio of 31.32. The price/earnings-to-growth ratio is 1.55.

What is NuVasive's EPS forecast for next year?

NuVasive's earnings are expected to grow from $1.77 per share to $2.31 per share in the next year, which is a 30.51% increase.

This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.